24 agosto 2014
A novel molecular pathway that causes an aggressive form of medulloblastoma has been identified by researchers. Now scientists suggest repurposing an anti-depressant medication to target medulloblastoma to help combat one of the most common brain cancers in children. The scientists say their laboratory findings in mouse models of the disease could lead to a more targeted and effective molecular therapy that would also reduce the harmful side effects of current treatments.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/TxWRSQAw6L0/140824152337.htm
